Concept Life Sciences, OpenBench partner on drug discovery services

Concept Life Sciences has signed a strategic partnership with OpenBench to deliver success-based drug discovery services targeted at early-stage biotech companies. The partnership will combine OpenBench’s discovery platform with Concept Life Sciences’ expertise in medicinal chemistry. OpenBench employs its structure-based AI to virtually screen trillions of compounds. Credit: Gorodenkoff / Shutterstock.com. Concept Life Sciences has signed a strategic partnership with OpenBench to deliver success-based drug discovery services targeted at early-stage biotech companies. The collaboration aims to accelerate hit identification for these companies through a fee-for-success approach. LOA and PTSR Model BNT-312 in Head And Neck Cancer Reports NPVM: Molecular…

Source: Pharmaceutical Technology